Zobrazeno 1 - 10
of 1 261
pro vyhledávání: '"Marcus Maurer"'
Autor:
Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben-Shoshan, Elizabeth Laws, Jennifer Maloney, Deborah Bauer, Allen Radin, Melanie Makhija
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2427-2441 (2024)
Abstract Introduction In chronic spontaneous urticaria (CSU), interleukin (IL)-4 and IL-13 may promote mast cell activation directly via IL-4 receptor expression, or indirectly via upregulated immunoglobulin E (IgE) production. Dupilumab significantl
Externí odkaz:
https://doaj.org/article/33337bbfe64f445c8596539250ffde4d
Autor:
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mösges, Zoltan Novak, Nikolaus Papadopoulos, Pablo Rodriguez del Rio, the Delphi Study Group
Publikováno v:
Drugs in Context, Vol 13, Pp 1-10 (2024)
Background: Second-generation oral H1-antihistamines, including bilastine, represent the emerging treatments of allergic rhinitis (including rhinoconjunctivitis) and chronic urticaria in both adults and children. This study analyses available evidenc
Externí odkaz:
https://doaj.org/article/ae0f855dbf244fa9950fe78f720e7985
Autor:
Thomas B. Casale, MD, Benjamin Trzaskoma, MS, Michael Holden, MD, Jonathan A. Bernstein, MD, Marcus Maurer, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100943- (2024)
The presence of angioedema, or deep skin swelling, in addition to hives (wheals) in patients with chronic spontaneous urticaria (CSU) can complicate disease management. There is evidence that omalizumab is effective for patients with CSU with angioed
Externí odkaz:
https://doaj.org/article/37ec73a1f4e641de8d5f4e7ac781d181
Autor:
Hugo W.F. Mak, MBBS, MRes(Med), Elaine Lee, MSc, Jane C.Y. Wong, MBBS, Karsten Weller, MD, Marcus Maurer, MD, Philip H. Li, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100290- (2024)
Background: Uncontrolled chronic urticaria (CU) can severely affect physical and psychosocial health as well as quality of life. Patient-reported outcome measures are crucial for measuring disease control. The Urticaria Control Test (UCT) is recommen
Externí odkaz:
https://doaj.org/article/6e16af2aa3d24f4ab19ab8b7345511c7
Autor:
Petra Staubach, Benedikt Bilo, Joachim W. Fluhr, Karoline Krause, Kanokvalai Kulthanan, Andac Salman, Connie Katelaris, Jonathan A. Bernstein, Marcus Maurer, Caroline Mann
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground There is a lack of real-life safety data on treatment options for chronic urticaria in the presence of comedication and comorbidities.Methods We present a single-center UCARE pilot study of 212 outpatients with chronic urticaria. P
Externí odkaz:
https://doaj.org/article/17f5501808da4e12a985be40da2ccf63
Autor:
Hugo W.F. Mak, MBBS, Jane C.Y. Wong, MBBS, Sophia W.M. So, MBBS, Dorothy L.Y. Lam, MSc, Karsten Weller, MD, Marcus Maurer, MD, Philip H. Li, MBBS, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100295- (2024)
Background: The impact of recurrent angioedema can be severely debilitating and remains difficult to quantify. Several standardized patient-reported outcome measures (PROMs), including the Angioedema Activity Score (AAS), Angioedema Quality of Life (
Externí odkaz:
https://doaj.org/article/8e6c2b725e5c45b5a287da7b80f5e924
Autor:
Raeda Mubariki, Reem Samara, Anna Maria Gimenez-Arnua, Marcus Maurer, Jacob Bejar, Elias Toubi, Zahava Vadasz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThe proximity of activated T cells and mast cells in the lesional skin of patients with chronic spontaneous urticaria (CSU) is held to contribute to the development of wheals and angioedema. In a previous study, we demonstrated that increas
Externí odkaz:
https://doaj.org/article/272c4190f22d4911ba80c4de1abcfa76
Autor:
Thomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, Karsten Weller, Annika Gutsche, Marcus Maurer, Markus Magerl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionLanadelumab is a first-line long-term prophylaxis (LTP) in hereditary angioedema (HAE). Real-life data on its long-term efficacy and safety are limited. It is unknown whether patients using lanadelumab need short-term prophylaxis (STP).Ob
Externí odkaz:
https://doaj.org/article/7536b60b93bf481ea32a454fc35cf1e6
Autor:
Lei Zhu, Xingxing Jian, Bingjing Zhou, Runqiu Liu, Melba Muñoz, Wan Sun, Lu Xie, Xiang Chen, Cong Peng, Marcus Maurer, Jie Li
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Chronic spontaneous urticaria (CSU) comes with gut dysbiosis, but its relevance remains elusive. Here we use metagenomics sequencing and short-chain fatty acids metabolomics and assess the effects of human CSU fecal microbial transplantation
Externí odkaz:
https://doaj.org/article/c2393565f8a6462c95084c292803ce5f
Autor:
Semra Demir, Deniz Eyice‐Karabacak, Emek Kocatürk, Derya Ünal, İlkim Deniz Toprak, Pelin Korkmaz, Ayşe Feyza Aslan, Işıl Göğem İmren, Bahar Dikicier, Nevzat Kahveci, Nida Öztop, Rabia Öztaş Kara, Halim İşsever, Marcus Maurer, Karsten Weller, Aslı Gelincik
Publikováno v:
Clinical and Translational Allergy, Vol 14, Iss 3, Pp n/a-n/a (2024)
Abstract Background Determination of control level in recurrent angioedema (RAE) is necessary to guide management. Here, we validated a Turkish version of the angioedema control test (AECT) for 4‐week (AECT‐4wk) and for 3‐month (AECT‐3mth) an
Externí odkaz:
https://doaj.org/article/47bbcef245a64b03ad70d47b43b4b223